المؤلفون: Wilkinson MJ; Division of Cardiovascular Medicine, Department of Medicine Cardiovascular Institute, University of California San Diego San Diego CA USA., Bajaj A; Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA USA., Brousseau ME; Cardiovascular and Metabolism Disease Area, Novartis Institutes for BioMedical Research Cambridge MA USA., Taub PR; Division of Cardiovascular Medicine, Department of Medicine Cardiovascular Institute, University of California San Diego San Diego CA USA.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2024 Mar 19; Vol. 13 (6), pp. e032031. Date of Electronic Publication: 2024 Mar 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases*/drug therapy , Cardiovascular Diseases*/genetics , Cardiovascular Diseases*/prevention & control , Anticholesteremic Agents*/adverse effects, Humans ; Cholesterol, LDL ; Proprotein Convertase 9/genetics ; Proprotein Convertase 9/metabolism ; RNA Interference ; PCSK9 Inhibitors ; Cholesterol ; RNA, Small Interfering/adverse effects

المؤلفون: Bétrisey S; Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern Switzerland.; Institute of Primary Health Care (BIHAM) University of Bern Switzerland., Haller ML; Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern Switzerland.; Institute of Primary Health Care (BIHAM) University of Bern Switzerland., Efthimiou O; Institute of Primary Health Care (BIHAM) University of Bern Switzerland.; Institute of Social and Preventive Medicine (ISPM) University of Bern Switzerland., Speierer A; Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern Switzerland.; Institute of Primary Health Care (BIHAM) University of Bern Switzerland., Del Giovane C; Institute of Primary Health Care (BIHAM) University of Bern Switzerland.; Department of Medical and Surgical Sciences for Children and Adults University Hospital of Modena and Reggio Emilia Modena MO Italy., Moutzouri E; Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern Switzerland.; Institute of Primary Health Care (BIHAM) University of Bern Switzerland.; Department of General Internal Medicine, Spital Emmental Burgdorf Switzerland., Blum MR; Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern Switzerland.; Institute of Primary Health Care (BIHAM) University of Bern Switzerland., Aujesky D; Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern Switzerland., Rodondi N; Department of General Internal Medicine, Inselspital Bern University Hospital, University of Bern Switzerland.; Institute of Primary Health Care (BIHAM) University of Bern Switzerland., Gencer B; Institute of Primary Health Care (BIHAM) University of Bern Switzerland.; Department of Cardiology Geneva University Hospital (HUG), University of Geneva Geneva Switzerland.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2024 Feb 20; Vol. 13 (4), pp. e030714. Date of Electronic Publication: 2024 Feb 07.

نوع المنشور: Meta-Analysis; Systematic Review; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Anticholesteremic Agents*/therapeutic use , Hemorrhagic Stroke*/chemically induced , Hemorrhagic Stroke*/epidemiology , Cardiovascular Diseases*/drug therapy , Stroke*/epidemiology , Stroke*/etiology , Stroke*/prevention & control, Humans ; Aged ; Cholesterol, LDL ; Randomized Controlled Trials as Topic ; Ezetimibe/adverse effects ; Triglycerides

المؤلفون: Kuwabara M; Toranomon Hospital Tokyo Japan., Sasaki J; International University of Health and Welfare Fukuoka Japan., Ouchi Y; Toranomon Hospital Tokyo Japan., Oikawa S; Fukujuji Hospital Tokyo Japan., Nakagawa K; Tohoku University Miyagi Japan., Sato M; Kyushu University Fukuoka Japan., Koba S; Showa University Tokyo Japan., Kono S; MedStat Corporation Fukuoka Japan., Saikawa T; Oita San-Ai Medical Center Oita Japan., Arai H; National Center for Geriatrics and Gerontology Aichi Japan.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2024 Feb 06; Vol. 13 (3), pp. e031865. Date of Electronic Publication: 2024 Jan 19.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Hypercholesterolemia*/drug therapy , Hypercholesterolemia*/epidemiology , Anticholesteremic Agents*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Coronary Artery Disease*/drug therapy, Aged ; Humans ; Cholesterol ; Ezetimibe/therapeutic use ; Hypolipidemic Agents/therapeutic use ; Drug Therapy, Combination

المؤلفون: Arca M; Department of Translational and Precision Medicine Sapienza University of Rome Rome Italy., Celant S; Italian Medicines Agency Rome Italy., Olimpieri PP; Italian Medicines Agency Rome Italy., Colatrella A; Italian Medicines Agency Rome Italy., Tomassini L; Italian Medicines Agency Rome Italy., D'Erasmo L; Department of Translational and Precision Medicine Sapienza University of Rome Rome Italy., Averna M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) University of Palermo Palermo Italy., Zambon A; Department of Medicine-DIMED University of Padua Italy., Catapano AL; Department of Pharmacological and Biomolecular Sciences Rodolfo Paoletti University of Milan and IRCCS Multimedica Milan Italy., Russo P; Italian Medicines Agency Rome Italy.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2023 Nov 07; Vol. 12 (21), pp. e026550. Date of Electronic Publication: 2023 Oct 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Homozygous Familial Hypercholesterolemia* , Hyperlipoproteinemia Type II*/drug therapy , Hypercholesterolemia*/drug therapy , Atherosclerosis*/drug therapy , Anticholesteremic Agents*/therapeutic use, Humans ; PCSK9 Inhibitors ; Cholesterol, LDL ; Proprotein Convertase 9 ; Retrospective Studies

المؤلفون: Shah NP; Duke University School of Medicine Durham NC USA.; Duke Clinical Research Institute NC Durham USA., McGuire DK; University of Texas Southwestern Medical Center Dallas TX USA.; Parkland Health and Hospital System Dallas TX USA., Cannon CP; TIMI Study Group, Brigham and Women's Hospital Boston MA USA., Giugliano RP; TIMI Study Group, Brigham and Women's Hospital Boston MA USA., Lokhnygina Y; Duke University School of Medicine Durham NC USA.; Duke Clinical Research Institute NC Durham USA., Page CB; Duke Clinical Research Institute NC Durham USA., Tershakovec AM; Merck & Co., Inc. Kenilworth NJ USA., Braunwald E; TIMI Study Group, Brigham and Women's Hospital Boston MA USA., Blazing MA; Duke University School of Medicine Durham NC USA.; Duke Clinical Research Institute NC Durham USA.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2023 Jul 04; Vol. 12 (13), pp. e029593. Date of Electronic Publication: 2023 Jun 22.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Diabetes Mellitus*/drug therapy , Diabetes Mellitus*/epidemiology, Ezetimibe/therapeutic use ; Drug Therapy, Combination

المؤلفون: Wang X; General Hospital of Northern Theater Command Shenyang China., Qiu M; General Hospital of Northern Theater Command Shenyang China., Cheng Z; The Fourth Hospital of Harbin Medical University Harbin China., Ji X; Daqing People's Hospital Daqing China., Chen J; Guangdong General Hospital Guangzhou China., Zhu H; The Affiliated Hospital of Xuzhou Medical University Xuzhou China., Tang Y; Peking University Third Hospital Beijing China., Huang Z; The First Affiliated Hospital of Wenzhou Medical University Wenzhou China., Su G; Jinan Central Hospital Jinan China., Wang G; The First Affiliated Hospital of Jinzhou Medical University Jinzhou China., Huang Z; The Third Xiangya Hospital of Central South University Changsha China., Yao Z; Tianjin People's Hospital Tianjin China., Lin J; The First Affiliated Hospital of Fujian Medical University Fuzhou China., Sun Y; China-Japan Friendship Hospital Beijing China., Li S; The First Hospital of Nanchang Nanchang China., Shao C; Shanghai Junshi Biosciences Co., Ltd. Shanghai China., Zhao Y; Shanghai Junshi Biosciences Co., Ltd. Shanghai China., Bai X; Shanghai Junshi Biosciences Co., Ltd. Shanghai China., Han Y; General Hospital of Northern Theater Command Shenyang China.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2024 Jun 04; Vol. 13 (11), pp. e033669. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Hypercholesterolemia*/drug therapy , Hypercholesterolemia*/blood , Hypercholesterolemia*/diagnosis , Cholesterol, LDL*/blood , Dyslipidemias*/drug therapy , Dyslipidemias*/blood , Dyslipidemias*/diagnosis, Humans ; Male ; Female ; Middle Aged ; China ; Treatment Outcome ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/administration & dosage ; Aged ; Double-Blind Method ; PCSK9 Inhibitors ; Adult ; Asian People ; Proprotein Convertase 9/immunology ; Proprotein Convertase 9/metabolism ; Biomarkers/blood ; Time Factors ; Drug Therapy, Combination ; Anticholesteremic Agents/therapeutic use ; Anticholesteremic Agents/adverse effects ; Anticholesteremic Agents/administration & dosage ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/administration & dosage ; East Asian People

المؤلفون: Lin CP; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine Chang Gung University Taoyuan Taiwan.; School of Medicine National Tsing Hua University Hsinchu Taiwan., Hsu TJ; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine Chang Gung University Taoyuan Taiwan., Tung YC; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine Chang Gung University Taoyuan Taiwan., Hsiao FC; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine Chang Gung University Taoyuan Taiwan., Chou SH; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine Chang Gung University Taoyuan Taiwan.; Graduate Institute of Clinical Medical Science, College of Medicine Chang Gung University Taoyuan Taiwan., Lin YS; School of Medicine National Tsing Hua University Hsinchu Taiwan.; Department of Internal Medicine, Taoyuan Chang Gung Memorial Hospital, College of Medicine Chang Gung University Taoyuan Taiwan.; Healthcare Center Chang Gung Memorial Hospital Taoyuan Taiwan., Chen SW; Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, College of Medicine Chang Gung University Taoyuan Taiwan.; Center for Big Data Analytics and Statistics Chang Gung Memorial Hospital Linkou Taiwan., Chu PH; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine Chang Gung University Taoyuan Taiwan.; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital Chang Gung University College of Medicine Taoyuan Taiwan.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2024 May 07; Vol. 13 (9), pp. e033780. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Amlodipine*/administration & dosage , Amlodipine*/adverse effects , Hypercholesterolemia*/drug therapy , Hypercholesterolemia*/complications , Hypercholesterolemia*/epidemiology , Hypertension*/drug therapy , Hypertension*/complications , Hypertension*/epidemiology , Atorvastatin*/administration & dosage , Drug Combinations* , Heptanoic Acids* , Pyrroles*, Humans ; Male ; Female ; Middle Aged ; Aged ; Taiwan/epidemiology ; Treatment Outcome ; Antihypertensive Agents/administration & dosage ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/adverse effects ; Retrospective Studies ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Anticholesteremic Agents/administration & dosage ; Anticholesteremic Agents/adverse effects ; Anticholesteremic Agents/therapeutic use ; Calcium Channel Blockers/administration & dosage ; Calcium Channel Blockers/adverse effects ; Calcium Channel Blockers/therapeutic use ; Blood Pressure/drug effects

المؤلفون: Kraaijenhof JM; Department of Vascular Medicine Amsterdam University Medical Centers, University of Amsterdam Amsterdam The Netherlands., Cronjé HT; Department of Public Health, Section of Epidemiology University of Copenhagen Copenhagen Denmark., Hovingh GK; Department of Vascular Medicine Amsterdam University Medical Centers, University of Amsterdam Amsterdam The Netherlands., Nurmohamed NS; Department of Vascular Medicine Amsterdam University Medical Centers, University of Amsterdam Amsterdam The Netherlands.; Department of Cardiology Amsterdam University Medical Centers, Vrije Universiteit Amsterdam Amsterdam The Netherlands., Gill D; Department of Epidemiology and Biostatistics, School of Public Health Imperial College London London United Kingdom., Zagkos L; Department of Epidemiology and Biostatistics, School of Public Health Imperial College London London United Kingdom.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2024 Jun 18; Vol. 13 (12), pp. e033190. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: PCSK9 Inhibitors* , Proteomics*/methods , Proprotein Convertase 9*/genetics , Proprotein Convertase 9*/metabolism, Humans ; Anticholesteremic Agents/therapeutic use

المؤلفون: Cuchel M; Division of Translational Medicine and Human Genetics, Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA., Lee PC; Division of Translational Medicine and Human Genetics, Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA., Hudgins LC; The Rogosin Institute/Weill Cornell Medical College New York NY., Duell PB; Center for Preventive Cardiology, Knight Cardiovascular Institute, and Division of Endocrinology, Diabetes, and Clinical Nutrition, Department of Medicine Oregon Health and Science University Portland OR., Ahmad Z; Division of Endocrinology, Department of Internal Medicine UT Southwestern Medical Center Dallas TX., Baum SJ; Flourish Research Boca Raton FL., Linton MF; Division of Cardiovascular Medicine, Department of Medicine Vanderbilt University Medical Center Nashville TN., de Ferranti SD; Department of Cardiology Boston Children Hospital Boston MA., Ballantyne CM; Baylor College of Medicine Houston TX., Larry JA; Ohio State University Wexner Medical Center Columbus OH., Hemphill LC; Massachusetts General Hospital Boston MA., Kindt I; DEARhealth INC. Los Angeles CA., Gidding SS; Geisinger Danville PA., Martin SS; Division of Cardiology, Department of Medicine, Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD., Moriarty PM; University of Kansas Medical Center Kansas City KS., Thompson PP; Hartford Hospital Hartford CT., Underberg JA; NYU Langone Medical Center New York NY., Guyton JR; Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine Duke University Medical Center Durham NC., Andersen RL; Lancaster General Health/Penn Medicine Lancaster PA., Whellan DJ; Thomas Jefferson University Philadelphia PA., Benuck I; Department of Pediatrics Feinberg School of Medicine Chicago IL., Kane JP; UC San Francisco San Francisco CA., Myers K; Family Heart Foundation Pasadena CA., Howard W; Atomo Inc. Austin TX., Staszak D; Atomo Inc. Austin TX., Jamison A; Family Heart Foundation Pasadena CA., Card MC; Family Heart Foundation Pasadena CA., Bourbon M; Unidade de I&D, Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa AND BioISI-Biosystems and Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa Lisboa Portugal., Chora JR; Unidade de I&D, Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa AND BioISI-Biosystems and Integrative Sciences Institute, Faculdade de Ciências, Universidade de Lisboa Lisboa Portugal., Rader DJ; Division of Translational Medicine and Human Genetics, Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia PA., Knowles JW; Family Heart Foundation Pasadena CA.; Division of Cardiovascular Medicine, Department of Medicine Cardiovascular Institute Stanford CA.; Stanford Diabetes Research Center Stanford CA.; Stanford Prevention Research Center Stanford CA., Wilemon K; Family Heart Foundation Pasadena CA., McGowan MP; Family Heart Foundation Pasadena CA.; Department of Medicine Section of Cardiovascular Medicine, Dartmouth-Hitchcock Medical Center Lebanon NH.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2023 May 02; Vol. 12 (9), pp. e029175. Date of Electronic Publication: 2023 Apr 29.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Homozygous Familial Hypercholesterolemia* , Cardiovascular Diseases*/drug therapy , Hyperlipoproteinemia Type II*/diagnosis , Hyperlipoproteinemia Type II*/epidemiology , Hyperlipoproteinemia Type II*/genetics , Atherosclerosis*/diagnosis , Atherosclerosis*/epidemiology , Atherosclerosis*/genetics , Anticholesteremic Agents*/therapeutic use, United States/epidemiology ; Humans ; Cholesterol, LDL ; Registries ; Homozygote

المؤلفون: Gao Y; Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD., Shah LM; Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD., Ding J; Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD., Martin SS; Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD.; Johns Hopkins Bloomberg School of Public Health Baltimore MD.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2023 Feb 07; Vol. 12 (3), pp. e028205. Date of Electronic Publication: 2023 Jan 10.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Anticholesteremic Agents*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use, Adult ; Humans ; Cholesterol ; Cholesterol, LDL ; Nutrition Surveys ; Triglycerides ; United States